4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-001026
Chief Scientific Officer sold 5,549 shares at $26.54 ($147,288)
- Chief Scientific Officer acquired 17,977 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Albright Charles Chief Scientific Officer | 2020-01-31 | Option exercise | +17,977 | 26,102 | D | ||
| Albright Charles Chief Scientific Officer | 2020-02-03 | Sale | −5,549 | $26.54 | $147,288 | 20,553 | D |
| Derivatives | |||||||
| Albright Charles Chief Scientific Officer | 2020-01-31 | Option exercise · Restricted Stock Units | −17,977 | 0 | D | ||
| Open-market sales · 5,549 sh · avg $26.54 · $147,288 | |||||||
Loading xslF345X03/edgar.xml…